BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10943744)

  • 1. Hyperthyroid Graves' disease after hemithyroidectomy for papillary carcinoma: report of three cases.
    Misaki T; Iwata M; Kasagi K; Iida Y; Akamizu T; Kosugi S; Konishi J
    Endocr J; 2000 Apr; 47(2):191-5. PubMed ID: 10943744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of pulmonary metastatic thyroid cancer complicated with Graves' disease.
    Suzuki K; Nakagawa O; Aizawa Y
    Endocr J; 2001 Apr; 48(2):175-9. PubMed ID: 11456264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
    Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
    J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic adenoma and papillary thyroid carcinoma in a patient with Graves' disease.
    Valenti TM; Macchia E; Pisa R; Bucalo ML; Russo V; Colletti I; Compagno V; Abbadi V; Donatelli M
    J Endocrinol Invest; 1999 Oct; 22(9):701-4. PubMed ID: 10595835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of sarcoidosis and sarcoid granuloma, papillary carcinoma, and Graves' disease in the thyroid gland.
    Zimmermann-Belsing T; Christensen L; Hansen HS; Kirkegaard J; Blichert-Toft M; Feldt-Rasmussen U
    Thyroid; 2000 Mar; 10(3):275-8. PubMed ID: 10779143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaplastic transformation of a papillary carcinoma of the thyroid in a patient with Graves' disease with varied activity of thyrotropin receptor antibodies.
    Fujikawa M; Okamura K; Sato K; Asano T; Yamasaki K; Hirata T; Ohta M; Mizokami T; Kuroda T; Fujishima M
    Thyroid; 1998 Jan; 8(1):53-8. PubMed ID: 9492154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay.
    Maugendre D; Massart C
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):89-96. PubMed ID: 11167931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.
    Takasu N; Yamashiro K; Komiya I; Ochi Y; Sato Y; Nagata A
    Thyroid; 2000 Oct; 10(10):891-6. PubMed ID: 11081255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative change of thyroid stimulating hormone receptor antibody level: possible marker for predicting recurrent hyperthyroidism in patients with Graves' disease after subtotal thyroidectomy.
    Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
    World J Surg; 1996 Sep; 20(7):801-6; discussion 806-7. PubMed ID: 8678954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship of psychological factors to the prognosis of hyperthyroidism in antithyroid drug-treated patients with Graves' disease.
    Fukao A; Takamatsu J; Murakami Y; Sakane S; Miyauchi A; Kuma K; Hayashi S; Hanafusa T
    Clin Endocrinol (Oxf); 2003 May; 58(5):550-5. PubMed ID: 12699435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithyroid drugs inhibit radioiodine-induced increases in thyroid autoantibodies in hyperthyroid Graves' disease.
    Nakazato N; Yoshida K; Mori K; Kiso Y; Sayama N; Tani JI; Nakagawa Y; Ito S
    Thyroid; 1999 Aug; 9(8):775-9. PubMed ID: 10482369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 1 alpha-hydroxyvitamin D3 on serum levels of thyroid hormones in hyperthyroid patients with untreated Graves' disease.
    Kawakami-Tani T; Fukawa E; Tanaka H; Abe Y; Makino I
    Metabolism; 1997 Oct; 46(10):1184-8. PubMed ID: 9322804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graves' ophthalmopathy after total thyroidectomy for papillary carcinoma.
    Giovansili L; Cayrolle G; Belange G; Clavel G; Herdan ML
    Ann Endocrinol (Paris); 2011 Feb; 72(1):42-4. PubMed ID: 21195999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
    Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T
    N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appearance of anti TSH-receptor antibodies and clinical Graves' disease after radioiodine therapy for hyperfunctioning thyroid adenoma.
    Regalbuto C; Salamone S; Scollo C; Vigneri R; Pezzino V
    J Endocrinol Invest; 1999 Feb; 22(2):147-50. PubMed ID: 10195384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid-stimulating antibody in a patient with euthyroid Graves' disease.
    Kubo T; Toki J; Kado Y; Kurihara M; Moriwake T; Kanzaki S; Seino Y
    Endocr J; 2000 Apr; 47(2):197-201. PubMed ID: 10943745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graves' disease and concurrent thyroid carcinoma. The importance of thyroid scintigraphy in Graves' disease.
    Joseph UA; Jhingran SG
    Clin Nucl Med; 1995 May; 20(5):416-8. PubMed ID: 7628144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical treatment of Graves' disease: subtotal or total thyroidectomy?
    Miccoli P; Vitti P; Rago T; Iacconi P; Bartalena L; Bogazzi F; Fiore E; Valeriano R; Chiovato L; Rocchi R; Pinchera A
    Surgery; 1996 Dec; 120(6):1020-4; discussion 1024-5. PubMed ID: 8957489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of Graves' disease and struma ovarii: case report and literature review.
    Mimura Y; Kishida M; Masuyama H; Suwaki N; Kodama J; Otsuka F; Kataoka H; Yamauchi T; Ogura T; Kudo T; Makino H
    Endocr J; 2001 Apr; 48(2):255-60. PubMed ID: 11456276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
    Rittmaster RS; Zwicker H; Abbott EC; Douglas R; Givner ML; Gupta MK; Lehmann L; Reddy S; Salisbury SR; Shlossberg AH; Tan MH; York SE
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3283-8. PubMed ID: 8784084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.